Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: update of the RENCOMP study with subgroup analysis of the …

M Lindskog, T Wahlgren, R Sandin, J Kowalski… - … Oncology: Seminars and …, 2017 - Elsevier
Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the …

M Lindskog, T Wahlgren, R Sandin, J Kowalski… - Urologic …, 2017 - europepmc.org
Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the …

M Lindskog, T Wahlgren, R Sandin… - Urologic …, 2017 - pubmed.ncbi.nlm.nih.gov
Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the …

M Lindskog, T Wahlgren, R Sandin, J Kowalski… - Urologic …, 2017 - diva-portal.org
Background: This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the …

M Lindskog, T Wahlgren, R Sandin, J Kowalski… - Urologic …, 2017 - diva-portal.org
Background: This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …